Our Terms of Use and Privacy Policy have changed. We think you'll like them better this way.

HealthTree Radio for AML: James Blachly, MD, Ohio State University

  • Broadcast in Health
HealthTree Radio for AML

HealthTree Radio for AML

×  

Follow This Show

If you liked this show, you should follow HealthTree Radio for AML.
h:2076829
s:12009495
archived

Progress in understanding AML and developing therapies that treat this blood cancer is occurring at an astounding pace. In this radio show, Dr. James Blachly, an AML expert from the James Comprehensive Cancer Center at Ohio State University shares a broad overview of the latest treatments for all stages of AML: precursor conditions like MDS, newly diagnosed AML and relapsed/refractory AML. Dr. Blachly will discuss combination therapies, new immunotherapies, new diagnostic technologies and new targeted treatments that are being used in the clinic today and in development in AML clinical trials. Dr. Blachly will simplify the significant work being performed all over the world by dedicated researchers who have the goal of curing all patients with AML.

Thanks to our episode sponsor, Amgen.

 

Comments